Ngā hua rapu - David R. Goldsmith

  • E whakaatu ana i te 1 - 16 hua o te 16
Whakamahine hua
  1. 1
    Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions

    Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions mā Brian J. Miller, David R. Goldsmith

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology

    Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology mā Brian J. Miller, David R. Goldsmith

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits

    Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits mā David R. Goldsmith, Mark Hyman Rapaport

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder

    Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder mā Brian J. Miller, David R. Goldsmith

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

    A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression mā David R. Goldsmith, Mark Hyman Rapaport, Brian J. Miller

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology

    Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology mā David R. Goldsmith, Mandakh Bekhbat, Neeti D. Mehta, Jennifer C. Felger

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic

    Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic mā Anna Zimmer, Alix Youngblood, Adam Adnane, Brian J. Miller, David R. Goldsmith

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia

    TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia mā David R. Goldsmith, Ebrahim Haroon, Andrew H. Miller, Gregory P. Strauss, P.F. Buckley, Brian J. Miller

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia

    Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia mā Mandakh Bekhbat, Michael T. Treadway, David R. Goldsmith, Bobbi J. Woolwine, Ebrahim Haroon, Andrew H. Miller, Jennifer C. Felger

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications

    Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications mā Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger, Andrew H. Miller

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Lipids and C-reactive Protein Predict Anhedonia and Reward Circuit Functional Connectivity Responses to Anti-cytokine and Dopaminergic Therapies in Patients with Depression

    Lipids and C-reactive Protein Predict Anhedonia and Reward Circuit Functional Connectivity Responses to Anti-cytokine and Dopaminergic Therapies in Patients with Depression mā Aditya Singh, Mandakh Bekhbat, David R. Goldsmith, Ngoc‐Anh Le, Evanthia C. Wommack, Zhihao Li, Ebrahim Haroon, Jennifer C. Felger

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression

    Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression mā Ebrahim Haroon, James R. Welle, Bobbi J. Woolwine, David R. Goldsmith, Wendy Baer, Trusharth Patel, Jennifer C. Felger, Andrew H. Miller

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder

    Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder mā Ebrahim Haroon, Alexander W. Daguanno, Bobbi J. Woolwine, David R. Goldsmith, Wendy Baer, Evanthia C. Wommack, Jennifer C. Felger, Andrew H. Miller

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder

    Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder mā David R. Goldsmith, Ebrahim Haroon, Bobbi J. Woolwine, Moon-Ryul Jung, Evanthia C. Wommack, Philip D. Harvey, Michael T. Treadway, Jennifer C. Felger, Andrew H. Miller

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    What does plasma CRP tell us about peripheral and central inflammation in depression?

    What does plasma CRP tell us about peripheral and central inflammation in depression? mā Jennifer C. Felger, Ebrahim Haroon, Trusharth Patel, David R. Goldsmith, Evanthia C. Wommack, Bobbi J. Woolwine, Ngoc‐Anh Le, Rachel Feinberg, Malú G. Tansey, Andrew H. Miller

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis

    Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis mā David R. Goldsmith, Ebrahim Haroon, Andrew H. Miller, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Tyrone D. Cannon, Barbara A. Cornblatt, Daniel H. Mathalon, Thomas H. McGlashan, Larry J. Seidman, Ming T. Tsuang, Scott W. Woods, Elaine F. Walker, Diana O. Perkins

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: